PremiumThe FlyNeuroOne Medical receives FDA 510k clearance for OneRF NeuroOne Updates Prospectus for $6.75 Million Offering NeuroOne Reports Strong Q3 2025 Financial Growth PremiumThe FlyNeuroOne Medical reports patient surpasses one year milestone of seizure freedom NeuroOne Medical appoints Johns as General Counsel, Corporate Secretary NeuroOne’s Earnings Call Highlights Growth and Challenges PremiumCompany AnnouncementsNeuroOne Faces Nasdaq Non-Compliance Notice NeuroOne Medical initiated with a Buy at Ladenburg NeuroOne Medical completes FDA submission for OneRF Ablation System RF